Vilacto Bio Inc. (fka VIBI)

[Majk76]

$VIBI - Vilacto Bio Inc. UPDATED SUMMARY



Copenhagen, Denmark-based Vilacto Bio Inc. is a biotech company that has developed the patented Lactoactive that’s based on colostrums,
the first milk from cows.
According to the company, it’s effective in treating skin conditions that arise from inflammatory diseases, diabetes, psoriasis and aging.

https://vilactobio.com/

https://vilacto.com

https://twitter.com/vilact_com
https://www.facebook.com/skincare.vilact/

https://vilactobio.com/company-news/


52Wk High - 0.6940 ( 09/24/2018 ) with OS aprox 90M
- Market Capital = $ 62 460 000

52Wk Low - 0.0013 ( 03/28/2019 ) with OS aproxx 597M
- Market Capital = $ 776 100

3M High - 0,0300 ( OS - 165M ) Market Capital - $ 4 950 000
6M High - 0,3000 ( OS - 98M ) Market Capital - $ 29 400 000
1Y High - 0,6940 ( OS - 90M ) Market Capital - $ 62 460 000
2Y High - 2,1300 ( OS - 90M ) Market Capital - $ 191 700 000

Yes, you see correct - $ 191 700 000 !!!

Market Capital - $ 191M / 675M OS = 0.2829 $ PPS - UNDERVALUED !!!

and even without granted patent bellow from March 15, 2019 !!!

https://www.otcmarkets.com/stock/VIBI/news/story?e&id=1310622

Vilacto Bio Canada Patent LACTOACTIVE® Granted
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its patent application for LACTOACTIVE® will be issued in near future.

The Company has already filed and received patents covering LACTOACTIVE® in the US, Europe and Hong Kong. The Canadian patent, when issued, is expected to give the company greater scope to continue developing the LACTOACTIVE® compound and bolster its international IP ownership position.

The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.

“Vilacto Bio now is in a stronger position than ever to leverage the potential of LACTOACTIVE,” said Vilacto Bio CEO Gert Anderson.

The main active component of LACTOACTIVE® and LACTOACTIVE iTHER® is colostrum, a natural substance that Vilacto Bio has refined and processed into a potent nanoparticle concentrate. In NPDDS form, the compound can be applied in deeper layers of the skin and, when injected, can penetrate cell walls to act directly on cytoplasm. The product is currently in the development stage and has not been approved for use by the FDA or any foreign agency.

Dilution decreased last week and should be over, therefore we ran from 0.0013 to 0.0053 recently !!!

Clearly visible on Level2 today - OTCX moved from 0.0032 to 0.0038 with just 500 000 shares slap, they have nothing !!!

UPDATED SHARE STRUCTURE ( OS )

04/04/2019 - 675,324,754
OS increased +78M shares
03/28/2019 - 597,064,715
OS increased +136M shares
03/21/2019 - 461,516,066


CEO - Gert Anderson
Current holding 83 500 000 shares


EDITOR'S PICK: CARMEN ELECTRA BY VILACT SKIN CARE

https://www.tripveel.com/tripveel/carmen-electra-vilact-skincare?fbclid=IwAR1G_4GEPdwtL5MNc7bwrUAGKnow2CHnWK0rDU7l28Oz6kAnINiEGpYMAd0

An Award-Winning Anti-Aging Skincare the Whole Family will want to Use: Vilact + a GIVEAWAY

http://mystylespot.net/award-winning-antiaging-skincare-giveaway/

STYLIST IVAN BITTON HOSTS CARMEN ELECTRA BY VILACT®
Carmen Electra photo shoot at stylist Ivan Bitton's showroom in Los Angeles.
Getting ready for some Vilact® promotion.
Notice her holding the Carmen Electra by Vilact® box when the video pans!

https://vilacto.com/blogs/news/stylist-ivan-bitton-hosts-carmen-electra-by-vilact%C2%AE

SHINE LIKE A STAR WITH VILACT - LIVE FROM THE OSCARS - CARMEN ELECTRA BY VILACT

THE FULL LINE OF VILACT® PRODUCTS

https://vilacto.com/collections/our-entire-line-of-vilact%C2%AE-products